Keys to strengthening the supply of routinely recommended vaccines: view from industry.
The vaccine enterprise in the United States is a remarkable success story that has resulted in freedom from disease for millions of children. Although some persons believe that this success is in danger because of recent vaccine shortages, the reality is otherwise. The existing system fundamentally works and should be strengthened and stabilized, to improve delivery of current vaccines and to establish a firm structure into which a new generation of vaccines can be integrated. Ten practical actions to strengthen supplies of vaccine and ensure the stability of these supplies were presented to the National Vaccine Advisory Committee in February 2002. The present article has been updated to include progress made since that time. By building on what is already in place and on what we know works, we can continue to ensure success for years to come.
Pisano
Wayne
W
Commercial Operations, Sanofi Pasteur, Swiftwater, PA 18370, USA. len.lavenda@sanofipasteur.com
D035881:Compensation and Redress; D004345:Drug Industry; D004335:Drug and Narcotic Control; D006801:Humans; D007114:Immunization; D014481:United States; D014486:United States Food and Drug Administration; D014612:Vaccines / Q000009:adverse effects / Q000600:supply & distribution*
D014612:Vaccines